CombiMatrix
Proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more.
Launch date
Market cap
-
Enterprise valuation
€30m (Public information from Jul 2017)
Irvine California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$17.5m | Debt | ||
$36.0m | Debt | ||
| N/A | N/A | IPO | |
$6.7m | Post IPO Equity | ||
| N/A | $1.2m | Post IPO Equity | |
| N/A | $12.0m | Post IPO Equity | |
| N/A | $52.1k | Debt | |
| N/A | $1.0m | Debt | |
$33.0m Valuation: $33.0m | Acquisition | ||
| Total Funding | - | ||
Recent News about CombiMatrix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.